Analysts slashed their price targets on Oracle Corp post Q3 results.
Piper Sandler analyst Brent Bracelin downgraded to Underweight from Neutral with a PT of $70 (8.7 percent downside), down from $100.
Analysts Slash Their PTs on Oracle as They Did Not Buy Its Growth Story
Save
The Oracle logo is shown on an office building in Irvine, Calif., on June 28, 2018. Mike Blake/Reuters
By Benzinga
Updated:
